Parkside Investments’s Lam Research LRCX Stock Holding History

Parkside Investments’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,000	Closed	-$470K	–	104
2019 Q2	$470K	Buy	+25,000	New	+$474K	0.12%	90

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parkside Investments's LRCX Position: Q3 2019 in Review

Parkside Investments sold out of Lam Research (LRCX) in Q3 2019, closing a stake of 25,000 shares — an estimated $470K sold.

Parkside Investments first reported a position in LRCX in Q2 2019 and held it in 1 quarter. The position peaked at $470K in Q2 2019. 881 funds tracked by Wall St. Rank hold LRCX as of Q3 2019.

Parkside Investments reported no remaining Lam Research position as of Q3 2019 after selling out during the quarter.
Parkside Investments sold 25,000 Lam Research shares in Q3 2019, an estimated $470K.
Parkside Investments first reported a position in Lam Research in Q2 2019 and held it in 1 quarter.
Parkside Investments's Lam Research position peaked at $470K in Q2 2019.
881 funds tracked by Wall St. Rank held Lam Research as of Q3 2019.

Based on Parkside Investments's 13F filing for Q3 2019, filed 6 Nov 2019.